ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00092924
Recruitment Status : Completed
First Posted : September 28, 2004
Last Update Posted : August 2, 2013
Sponsor:
Information provided by:
Human Genome Sciences Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2005
  Actual Study Completion Date : March 2005